ArticleFrontiers in oncology2026
Efficacy and safety of traction-assisted endoscopic submucosal dissection for superficial gastric neoplasms: a meta-analysis of randomized controlled trials.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Endoscopic submucosal dissection (ESD) remains technically demanding for superficial gastric neoplasms, particularly during submucosal layer dissection which is often time-consuming and associated with procedural risks. While traction-assisted ESD has been proposed to enhance visualization and facilitate safer dissection, current evidence regarding its efficacy and safety remains inconsistent. Methods: We conducted a comprehensive meta-analysis of randomized controlled trials (RCTs) comparing traction-assisted versus conventional ESD for superficial gastric neoplasms. Primary outcome was procedure time, with secondary outcomes were resection completeness ( Results: Seven RCTs involving 1476 patients were included. Meta-analysis demonstrated that traction-assisted ESD significantly reduced procedure time compared to conventional ESD (SMD: -0.23, 95% CI: -0.44 to -0.02; Conclusions: Traction-assisted ESD appears to be an efficient and safe technique for superficial gastric neoplasms, particularly for small lesions (≤20 mm) and those in technically challenging locations. Notably, the procedure time benefit was significant only among less experienced operators, suggesting that traction may be most valuable for lowering the technical threshold in non-expert hands. However, given the observed sensitivity to individual studies, current evidence should be interpreted with caution. Further large-scale, multi-center RCTs are warranted to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.